Let's be real here, this is a multiple phase 3 Biotech, one already commenced funded by the WHO, one due to commence in the coming days/weeks, and 2 in the planning/organising stage and we outstanding previous data, and our market cap is $50m. it is criminally undervalued. Yes a few (including me) was disappointed with the share price action after the last trial (which still garnered good results) we have been presented with the buying opportunity of a lifetime. I never expected to own any more DXB shares going into previous trial results but I've been accumulating like a mad man ever since. Unbelievable
DXB Chart, page-9
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.0¢ |
Change
0.015(4.62%) |
Mkt cap ! $186.8M | |||
| Open | High | Low | Value | Volume |
| 32.5¢ | 35.0¢ | 32.5¢ | $1.004M | 2.972M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 709817 | 34.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.5¢ | 176092 | 1 |
View Market Depth
| Last trade - 16.10pm 14/05/2024 (20 minute delay) ? |
|
|||||
|
Last
34.5¢ |
Change
0.015 ( 6.12 %) |
||||
| Open | High | Low | Volume | ||
| 32.5¢ | 35.0¢ | 32.5¢ | 2371193 | ||
| Last updated 15.55pm 14/05/2024 ? | |||||
| DXB (ASX) Chart |